We are delighted that two more of our projects have been approved for funding by Interreg 2Seas.
PATH 2 has secured more than €5 million of European funding in its €8.5 million partnership involving 13 organisations from the UK, The Netherlands, France and Belgium and will enable women, families and healthcare professionals to prevent, diagnose and successfully manage mild and moderate PMI (perinatal mental health issues) via radical systemic change, developing an inclusive, holistic health structure: demand driven and co-created with existing patients and expectant/new parents.
To read more about PATH 2 go to: http://www.healthandeuropecentre.nhs.uk/home-3/projects/current-projects-2/path/
SHIFT has secured more than €2.5 million of European funding in its €4.2 million partnership involving 11 organisations from the UK, The Netherlands, France and Belgium (see below for partner details) and the project’s objective is to empower people aged 45+ to participate in sexual health services and to improve their sexual health and wellbeing, with an additional and specifically adapted focus on socio-economically disadvantaged groups across the 2Seas area.
To read more about SHIFT go to: http://www.healthandeuropecentre.nhs.uk/home-3/projects/current-projects-2/shift/
The Bill & Melinda Gates Foundation will contribute €54 million ($62.5 million) to EU efforts to strengthen diagnostic health services in Sub-Saharan Africa under the External Investment Plan.
This cooperation will help to mobilise private investment in laboratory facilities providing timely, cost-effective and accurate diagnostic services for diseases such as tuberculosis, HIV, and malaria, as well as support maternal and child healthcare. This will allow doctors to detect diseases earlier, respond faster and better targeting treatments.
To read more about this on the European Commission website go to: European Commission – PRESS RELEASES – Press release – EU and Bill & Melinda Gates Foundation join forces to support health services in Africa
Having submitted a number of projects earlier this year, we at the Health and Europe Centre are thinking ahead to new projects to be submitted for EU Interreg funding.
Community empowerment: making social public services accessible to vulnerable people with the Moms for Moms project developed by Community Center De Mussen in the Netherlands serving as a pilot for the project.
Better emergency mental health care: building on the existing work undertaken by the Stockholm Region’s PAM ambulance: when a caller rings the emergency number (fire, police, ambulance) they are asked if it relates to mental health, if so, the PAM ambulance is sent with mental health nurses and a paramedic on board. The project will take this learning and expand it, to include the integration of mental health apps, to provide a better emergency mental health care system for all the partner regions involved.
For more information about these projects you can contact: firstname.lastname@example.org
Identifying, disseminating and transferring best practices is a priority for the EU in order to support the progress towards health promotion and non-communicable disease prevention in Europe to reach the Sustainable Development Goal 3.4 and the nine UN/WHO global voluntary targets.
This portal is a “one-stop shop” for consulting good and best practices collected in actions co-funded under the Health Programmes and submitting practices for assessment. All practices in the area of health promotion, disease prevention and management of non-communicable diseases are welcome. Those practices which will be selected as “best” against the criteria adopted by the Steering Group on Prevention and Promotion will also be published on this portal.
To go to the Best Practice Portal: https://webgate.ec.europa.eu/dyna/bp-portal/index.cfm
The European Cancer Information System provides the latest information on indicators that quantify cancer-burden across Europe. It permits the exploration of geographical patterns and temporal trends of incidence, mortality and survival data across Europe for the major cancer entities.
The purpose of the web-application is to support research as well as public-health decision-making in the field of cancer and to serve as a point of reference and information for European citizens.
To read more about the European Cancer Information System go to: ECIS – Home – European Commission
The Study “Cross-border cooperation: capitalising on existing initiatives for cooperation in cross-border regions” published by the Commission today maps EU-funded cooperation projects for the period 2007 to 2017 in EU and EEA countries and Switzerland; provides insight into opportunities and challenges for cross-border cooperation in healthcare; and offers guidance to local and regional authorities and other parties who are interested in starting a health-related cooperation project.
To read more about the Cross-border cooperation: capitalising on existing initiatives for cooperation in cross-border regions go to: http://ec.europa.eu/newsroom/sante/newsletter-specific-archive-frame.cfm?archtype=specific&newsletter_service_id=327&newsletter_issue_id=7986&page=1&fullDate=Tue%2027%20Mar%202018&lang=default
To truly understand the needs of adolescents, it is vital to listen to adolescents themselves. This was a central feature on the agenda of the first ever inter-country meeting and international conference addressing the mental health and well-being of adolescents living in central Asia, which took place on 17–20 January in Almaty, Kazakhstan. The meeting was hosted by the Government of Kazakhstan and organszed by the United Nations Children’s Fund (UNICEF), in collaboration with WHO. Country delegations from Belarus, Kyrgyzstan, Tajikistan, Ukraine and Uzbekistan, as well as Kazakhstan, participated in the exchange of knowledge, experiences and plans to better understand and address the mental health needs of adolescents.
To read more about understanding the mental health needs of adolescents go to: WHO/Europe | Understanding and addressing the mental health needs of adolescents
The Companion Report draws cross-cutting conclusions from the 28 Country Health Profiles. These highlight shared policy objectives across the EU countries, and reveal potential areas where the European Commission can be of help in facilitating mutual learning and exchange of good practice
The European Commission’s Companion Report, published alongside the Country Health Profiles, is made up of two parts. The first deals with themes that are prominent across the Country Health Profiles, such as:
- The shift towards health promotion and disease prevention
- A stronger role for primary care
- A rethink on fragmented service delivery
- Proactive planning and forecasting in the health workforce
- Better patient-centred data across the EU
The second part of the report features key findings from the 28 Country Health Profiles prepared by the OECD and the European Observatory on Health Systems and Policies.
To read more about the report on the European Commission website go to: Companion Report – European Commission
The start of the month the coming into operation of further aspects of the mutual recognition agreement between the European Union and the United States to recognise inspections of manufacturing sites for human medicines conducted in their respective territories. This agreement, which updates the agreement from 1998, allows for recognition of each other’s inspection outcomes and hence for better use of inspection expertise and resources.
In June, the European Commission confirmed that the US Food and Drug Administration has the capability, capacity and procedures in place to carry out good manufacturing practice inspections at a level equivalent to the EU. Today, the FDA confirmed the capability of eight EU Member States (Austria, Croatia, France, Italy, Malta, Spain, Sweden, and United Kingdom). The remaining inspectorates will continue to be assessed until 15 July 2019.
To read more about this mutual recognition go to the EMA website: European Medicines Agency – News and Events – EU-US mutual recognition of inspections of medicines manufacturers enters operational phase
In the WHO European Region, 42 of 53 countries have interrupted endemic transmission of measles, and 37 Member States have interrupted endemic transmission of rubella as of the end of 2016. This was determined by the European Regional Verification Commission for Measles and Rubella Elimination (RVC) at its 6th meeting in June 2017.
“I congratulate each country for fulfilling the commitment to protect its people from measles and rubella and collectively moving the European Region closer to its elimination goal,” said Dr Zsuzsanna Jakab, WHO Regional Director for Europe. “However, we cannot become complacent now. Outbreaks continue to cause unnecessary suffering and loss of life.”
To read more about this on the WHO/Europe website: http://www.euro.who.int/en/media-centre/sections/press-releases/2017/measles-no-longer-endemic-in-79-of-the-who-european-region